Glucose Metabolism and Catecholamine Responses during Physical Exercise in Non-Insulin - Dependent Diabetes by Turgan, Nevbahar et al.
Eur J Clin Chem Clin Biochem 1996; 34:683-689 © 1996 by Walter de Gruyter · Berlin · New York
Glucose Metabolism and Catecholamine Responses during
Physical Exercise in Non-Insulin-Dependent Diabetes
Nevbahar Turgan\ Canan fyket2, Fiisun Hamulu3, Semra Elmaci4, Candeger Yilmaz3, Butan Ersöz1 and
fetin Biegen4
1
 Department of Clinical Biochemistry
2
 Research Laboratory
3
 Department of Endocrinology
4
 Department of Sports Medicine
Ege University School of Medicine, Bornova, Izmir, Turkey
Summary: Blood glucose, lactate, insulin, C-peptide, norepinephrine and epinephrine concentrations were
determined in non-insulin-dependent diabetic patients and in healthy controls before, during and after moderate
exercise, to evaluate the effects of physical exercise on glucoregulation. Ten diabetic and ten healthy control
females bicycled 14 minutes at 60% of their maximal heart rates. In the diabetic patients, there were no
significant changes in blood glucose levels post-exercise, while in controls the 60 minute post-exercise levels
were higher than those measured in mid-exercise (p < 0.05). Lactate concentrations increased with exercise in
both groups in a similar manner, with highest values at the end of exercise. No significant changes in insulin
and C-peptide levels were induced with exercise in either group. Norepinephrine and epinephrine concentrations
increased 2.5-3 fold with exercise in both groups (p < 0.05 for all values) but in the diabetics an earlier and
prolonged catecholamine response was observed. We propose that catecholamines prevent hypoglycaemia during
exercise when changes in insulin and C-peptide do not occur. In diabetic patients with good metabolic control,
the glucoregulatory response to exercise is not worse than in anthropometrically similar controls with similar
levels of fitness.
Introduction
The beneficial effects of exercise on glucose metabolism
in diabetic patients has been under investigation for
some considerable time. Evidence has been presented
for improved insulin action during exercise in both insu-
lin-dependent and non-insulin-dependent diabetic pa-
tients (1). Due to its additional beneficial effects on car-
diorespiratory fitness, psychological well-being, blood
lipid profile, adiposity and blood pressure, exercise
training became an important component of the treat-
ment of diabetic patients (2, 3). Most of the positive
effects of exercise seem to benefit non-insulin-depen-
dent diabetic patients through improved peripheral insu-
lin sensitivity and enhanced insulin binding to receptor
sites on the muscle cell, thus increasing muscle glucose
uptake without changing insulin levels (4). At exercise
intensities of ~ 50—60% of VO2max (moderate exer-
cise), blood glucose concentrations remain stable in pa-
tients with diabetes that is under good metabolic control
(5). In this situation, euglycaemia is usually maintained
due to feedback signals from glucosensors sensitive to
minute decrements in glycaemia elicited by the increase
in peripheral glucose utilization. These signals also stim-
ulate the secretion of counterregulatory hormones (cate-
cholamines, glucagon, cortisol and growth hormone)
which exert insulin antagonistic effects. Among these,
catecholamines (emergency hormones) rapidly influence
glucose control by transiently increasing hepatic glucose
production, inhibiting peripheral glucose utilization for
several hours and supplying the liver with gluconeo-
genic substrates (lactate, pyruvate, alanine) (6). In ad-
dition to the insulin resistance caused by circulating
catecholamines, the increased sympathetic activity of
norepinephrine at the sympathetic nerve endings in the
islets of Langerhans diminishes insulin release during
exercise, thereby helping to maintain glucose homeo-
stasis (7). In the skeletal muscle, epinephrine binds
to ß-adrenergic receptors on the membrane, activates
phosphorylase a and initiates glycogen breakdown with
a consequent increase in lactate production (8). Under
basal conditions, the plasma content of norepinephrine
is 3—4 times greater than that of epinephrine. This is
attributed to the fact that norepinephrine, which is a
major neurotransmitter of the sympathetic nervous sys-
tem, is secreted into the circulation from the terminal
nerve endings. Changes in plasma norepinephrine
content during exercise reflect sympathetic nervous
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system activity. The major source of circulating epi-
nephrine is the adrenal glands (chromaffin cells) which
release catecholamines in response to sympathetic sti-
mulation and other influences such as hypoxia or hy-
poglycaemia (9).
Most of the studies on exercise and glucoregulation have
assessed the effects of intense exercise on diabetes (ΙΟ-
Ι 3). Relatively little information is available regarding
the regulation of glucose metabolism in non-insulin-de-
pendent diabetic patients during short-term moderately
intense exercise. Because individuals are being encour-
aged to perform moderate exercise based on the expecta-
tion that this will improve their glycaemic control, we
attempted to assess the effects of moderately intense ex-
ercise on hormonal and metabolic responses, with spe-
cial emphasis on catecholamines, during and after exer-
cise in patients with non-insulin-dependent diabetes.
Materials and Methods
Subjects and procedures
Participants in the study were twenty women, ten with non-insulin-
dependent diabetes and ten controls. Each had been informed of
the nature and purpose of the study and gave consent as prescribed
by the institutional human ethics committee. The mean age was
45.67 ±2.16 (± SEM) years for the diabetic group and 39.17
±1.83 for the control group. The mean duration of diabetes was
3.05 ± 0.82 years. All diabetics were treated with oral antidiabetic
agents: second generation sulphonylurea gliclazide (maximum 80
mg, b. i. d.). There was no clinical evidence of macrovascular,
microvascular or neurological complications of diabetes mellitus.
All had normal exercise electrocardiograms. None participated in
any regular fitness programme and their level of fitness ranged
from poor to average. Anthropometric and exercise data are pre-
sented in table 1.
Protocol
Two days before each study, the subjects exercised on a cycle er-
gometer during which heart rates, electrocardiograms, systolic and
diastolic blood pressures were monitored. The level of exercise
predicted to give 60% of maximal heart rate was determined and
the corresponding VO2max was estimated indirectly according to
Asians-Rhyming** nomogram. Weight (kg), height (m), body mass
index (kg/m2), waist/hip ratio, skinfold thickness (biceps, triceps,
subscapular, abdominal, quadriceps, mm), % body fat, indirect
VO2max and workload (watts) were recorded for all subjects. Exer-
cise studies were performed in the morning in the fasting state and
started after a minimum of 1 hour after a catheter with a three-way
stopcock had been inserted in an antecubital vein. The vein was
kept patent by heparin diluted 20-fold with 9 g/1 NaCl. All subjects
exercised at 60% of their maximal heart rates for a period of 14
minutes. Basal (rest), mid-exercise (7 min), end-exercise (14 min)
heart rate, systolic and diastolic blood pressures were recorded.
Electrocardiograms were recorded before, during and after exer-
cise. Blood samples were drawn at rest, midpoint (7 min) of exer-
cise, at the end of exercise (time 0 of recovery) and at 20 and 60
minutes of recovery.
Analytical methods
Serum glucose concentrations were determined by the glucose oxi-
dase method on a Hitachi 704 analyser (intra-assay precision 2.1%;
inter-assay precision 3.2%). Plasma lactate concentrations were de-
termined by the kinetic method, using the UV kit from Boehringer-
Mannheim, Germany (intra-assay precision 3.6%; inter-assay
precision 4.7%). Serum insulin and C-peptide were determined by
radioimmunoassay (insulin with the DPC Coat-A-Count RIA kit;
C-peptide with the Diagnostic Systems Lab, RIA kit). Intra-assay
precision was 4.4 and 5.7%. inter-assay precision 5.1 and 7.8%,
for insulin and C-peptide, respectively.
Plasma norepinephrine and epinephrine concentrations were deter-
mined by high performance liquid chromatography (HPLC). The
Tab. 1 Subjects and exercise data (mean ± SEM)
Control
(n = 10)
Age (a)
Height (cm)
Weight (kg)
Body mass index (kg/m2)
Waist/hip ratio
Abdominal skinfold (mm)
Body fat (%)
Indirect VO2max (ml/kg · min)
Workload (watt)
Heart rate (min"1)
rest
mid-exercise (7 min)
end-exercise (recovery 0)
recovery-20 min
recovery-60 min
Systolic blood pressure (mm Hg)
rest
end-exercise
Diastolic blood pressure (mm Hg)
rest
end-exercise
39.17
157.33
74.45
29.98
0.92
46.37
27.08
30.07
32.50
77.17
105.67
109.83
85.13
81.83
115.5
123.3
80.0
83.3
±
±
-+-
Hh
+
±
1
3
.83
.05
4.53
1.22
0.04
2.02
± 1.28
±
-t-
±
H:
±
±
-j-
-h
±
-1-
+
3
3
2
5
5
2
2
5
5
5
.04
.59
.96
.01
.77
.66
.64
.5
.6
.16
4.8
Diabetics
(n = 10)
45.
158.
72.
28.
6
33
77
83
±
-+-
±
±
0.94 ±
44.77 ±
25.
25.
34.
84.
104.
105.
89.
84.
52
35
17
17
5
67
00
67
2
1
6
1
0
.16
.76
.33
.97
.01
3.26
± 1.48
± 1.37
± 5.07
± 2.51
± 1.38
± 1.56
± 2.03
± 0.80
116.7 ±
120.
83.
88.
1
3
3
17.8
± 6.3
± 3.3
± 2.8
P
NS
NS
NS
NS
NS
NS
NS
NS
NS
MC1 NO
MCIN O
NS1NO
.MCIN O
NS
MOIN Ο
NS
KJOIN ο
NS
NS: not significant
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HPLC system consisted of an electrochemical detector (Shimadzu
LC-6A), a solvent delivery system (Shimadzu LC GAD), a Rheo-
dyne Model 7125 injector with a loop of 100 ml. A glassy carbon
working electrode was set at 650 mV versus an Ag/AgCl reference
electrode. The sensitivity of the detector was maintained at 1.0 nA
full scale.
For sample pretreatment, the commonly used extraction pro-
cedure based on the selective adsorption on alumina at pH 8.6,
followed by elution with perchloric acid at a low pH between
1.0 and 2.0, was applied with technical modifications (14, 15).
Internal standard (100 μΐ) (I g/1) dihydroxybenzyiamine in 0.2
mol/1 HC1O4) was added to 1 ml of plasma; 30 mg of acid
washed alumina (WA-4) was added, followed by 5 min of vigor-
ous shaking.
The pH of the solution was adjusted to above 8.0 with 1 ml Tris
buffer (1 mol/1 Tris base + 20 mmol/1 Na2EDTA + 10 mmol/1 so-
dium metabisulphite; pH = 8.6). After shaking for another 10 min
the sample was centrifuged for 10 min at 2000 g and 4°C. The
supernatant was discarded and the alumina was washed three times
with 1 ml cold water with brief centrifugation between washes. The
catecholamines were extracted with 125 μΐ 0.2 mol/1 HC1O4 with
vortex mixing for 5 min and final centrifugation for 10 min at
2000 g 4 °C. Fifty μΐ of eluant was then injected into the HPLC
column (100 mm X 4.6 mm C18 reverse phase column packed
with 3 mm particles of Alltech Adsorbosphere). The mobile phase
consisted of 0.025 mol/1 citric acid, 0.025 mol/1 NaH2PO4, 0.005
mol/1 Na2EDTA, 34 mg/1 octane sulphonic acid (Na salt), pH was
adjusted to 3.4 with 850 g/kg H3PO4. Flow rate was 1 ml/min. The
chromatogram was analysed by computer integration (model CR-
4A Shimadzu).
Linear calibration plots of both catecholamines were obtained in
the expected ranges for plasma. Recovery rates (62—88%) and co-
efficients of variation (2.4-6.9) were satisfactory.
Statistics
The data are presented as means ± SEM. Wilcoxon's ranking test
was used to determine whether significant changes occurred with
time within the groups. Mann-Whitney's ranking test for unpaired
data was used to determine differences between diabetic and con-
trol subjects. Pearson correlation analysis was used for the assess-
ment of correlations between different parameters. A p value of
less than 0.05 was considered significant.
Results
There were no significant differences between the two
groups with respect to anthropometric quantities, work-
load, heart rate or blood pressure (tab. 1). The electrocar-
diograms at rest, and during and after exercise were nor-
mal in all subjects.
Basal values of lactate, C-peptide, norepinephrine and
epinephrine were not significantly different between
the two groups. Glucose concentrations were signifi-
cantly higher in the diabetics (p < 0.01 for all values,
tab. 2). HbA]c values differed significantly between
controls and diabetics: 3.2 ± 0.5% and 8.6 ± 0.8%,
respectively (p < 0.01). Basal insulin levels were sig-
nificantly higher in the diabetics (p < 0.01) (tab. 2).
Blood glucose alterations during and after exercise in
both groups are shown in figure 1. During exercise and
up to 60 ruin into the recovery phase, there were no
significant changes in blood glucose levels in the dia-
betic group. However, in controls, at 60 min into the
ι >
fi3 "o
X ^0> ci i
<u x~x
· W
8§Γ§·
'? II Sj- II OO
T-j co «
ε U
* g g
8 'S 15 ^ 2
4) ""* "3Ill's
^ V»·' 4J
<y> O
•'S 'S c£··- J
Cu «β 'S
0 £\S>
1 & 's
C > '·£·i§i
.S ^ oo
— c
cT'c c
tu
— - o «g s s
s ·| s s
•β S +1 V
•fli
H N^2 'S
e
o
&
1
0
/-"s
p
p
g
1
/•—N
O
p
o1
"*
o
<&
ω
1
α
1c
^
o
^^
B
1
c
o
O
.
J
-8
S
^
2
c
0
o
1Q
1
0
U
.
1
s
o o o o
Is* Γ-» CN ^ —
+1 +1 Ή -H +1
o o o o o
τί· co ro vo «n
o o o o o
£J ZU ΖΠ 2 °°
+1 +1 f l +1 -H
o o o o o§ vo oo r-· r*oo r^ r*- «n
oo ON uS cn
+1 +1 +1 +1 +1
»r» r^. r^ vo vo
•^ J· "^  ·^ Ό *r>
•κ·
oo — CN »ο ·^
r^ vo co ο ο
+1 +1 +1 +1 +1
VO «Ο Ο νο ·^
ON vo Ό ON ooCN O CN CN ON
0
Λ Ό ο α
«n vo co vo CN
— CO CN CN CN
0
+1 +1 +1 +1 +1
Ό Tf WO TT Ο
CN ^ CN VO rf
^- CN CN — — '
« 0 0
OO Ό — ' ON r*
CN ·^ ·ζΤ CN CO
Ο Ο Ο Ο Ο
+1 +1 +1 Ή +1
«Ο *— ι Tf OO Ι-Ο ON ON CN O
CN CN CN CN CN
<Λ ^T ON -^ CO
~
+1 +1 +1 +1 +1
vo ON CN -^T »n
»o ^r r* oo r^·
VO »O CO O —
ON O »O O "^
o" ~ ~ — «" — ί
+1 Ή +1 +1 +1
Tf vo OO ^ " ^f
t^ oo vo oo vo
ON ON O ON O
£>£·<υ υ
ω ω > >
^.22 . 2 8 8
S 2 2 g g
<β ω ο
ex x C CD ο ·*~ *£*
«•ύ-ύ ε ε
£ S « S S
»— CN CO ^ · WO
* J^ *2 *2 ^ *Q
> > > > >
— — CM rn ro
Λ ' W ' 'S" U ' 0 '
l*ZZZZ
° * " * " "
s
<N
a··
ω
3
1
73
l^t
S
v
ex
686
* . '
TYirgan et al.: Glucose metabolism and catecholamines during exercise in type 2 diabetes
recovery phase, glucose was significantly higher than in
mid-exercise (p < 0.05) (tab. 2).
Blood lactate concentrations increased markedly at the
midpoint (7 min) and at the end of exercise in both groups
(for all values p < 0.05 vs. basal) (tab. 2). As shown in
figure 2, values at the end of exercise were higher than the
values obtained at 20 and 60 min of recovery in both
groups (p < 0.05). Only in the diabetic group were mid-
exercise lactate levels significantly higher than those after
20 min of recovery (p < 0.05). The basal lactate values,
as well as those measured in the middle of exercise, at the
end of exercise, after 20 min recovery and after 60 min
recovery did not differ significantly in the control and the
diabetic group (tab. 2).
During exercise and in the recovery period, there were no
significant changes in the insulin levels within each group
and between the two groups. The basal insulin levels of
the diabetic patients were, however, significantly higher
than those of the controls (p < 0.01) (tab. 2).
C-peptide levels did not show significant changes in re-
sponse to exercise in both groups (tab. 2).
Basal norepinephrine and epinephrine values were sim-
ilar in both groups (tab. 3). Exercise increased the
norepinephrine and epinephrine levels 2.5—3-fold with
maximal values at the end of exercise in both groups
(fig. 3 and 4). In both groups, values at the end of
exercise were significantly higher (p < 0.05) than the
basal values and those measured in mid-exercise and
after 20 min and 60 min recovery. In addition, in the
diabetics, mid-exercise and 20 min recovery values for
norepinephrine, and mid-exercise epinephrine concen-
trations were significantly higher than basal values
(p < 0.05). A further difference between controls and
diabetics was that the norepinephrine and epinephrine
values did not differ significantly between 20 and 60
min of recovery in the controls, whereas in the dia-
betic patients, the 20 min recovery values for norepi-
nephrine and epinephrine were higher than the 60 min
recovery levels (tab. 3).
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Fig. l Mean plasma glucose concentrations during exercise and
for 60 min after exercise in normal and diabetic subjects. Blood
samples were drawn before exercise (Pre), at the midpoint (Mid
7 min), at the end of exercise (End, recovery 0), and after 20 and
60 minutes of recovery. Zero of the recovery time scale is at End;
D denotes diabetics and Δ controls.
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Fig. 2 Mean plasma lactate concentrations during exercise and for 60 min after exercise in normal -and
diabetic subjects. See figure 1 for key to abbreviations.
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Norepinephrine and epinephrine concentrations in re-
sponses to exercise correlated in both groups (r = 0.97,
p < 0.01 in controls and r - 0.87, p < 0.05 in diabetics).
On the other hand, epinephrine correlated with heart rate
in both groups (r = 0.82, p < 0.05 in controls and
r = 0.91, p < 0.01 in the diabetic group). A strong posi-
tive correlation between epinephrine and lactate
(r = 0.903, p < 0.02) was found in diabetics but not in
controls.
Discussion
In the present study, we observed that in healthy women
subjects with a body mass index of - 30 kg/m2, after
Tab. 3 Plasma norepinephrine and epinephrine values of patients (n = 10) and controls (n = 10)
at rest, mid-exercise, end-exercise (recovery 0), 20 min and 60 min recovery.
Mean values ± SEM are given.
Norepinephrine (nmol/1) Epinephrine (nmol/1)
Diabetic Control Diabetic Control
1.
2.
3.
4.
5.
P
Rest (basal)
Mid-exercise
End-exercise
20 min recovery
60 min recovery
< 0.05 for all values
0.357 ±
0.711 ±
1.501 ±
0.791 ±
0.346 ±
a: I vs 2
b: 1 vs 3
e: 1 vs 4
d: 2 vs 3
e: 3 vs 4
f: 3 vs 5
*:4 vs
0.044a'b'c
0.070d
0.107e*f
0.1 08*
0.03
0.498 ±
0.612 ±
1.504±
0.701 ±
0.385 ±
fl: 1 vs 3
b: 2 vs 3
c: 3 vs 4
d: 3 vs 5
0.1 27a
0.036b
0.161C
0.150
0.073d
0.477 ±
0.740 ±
1.028±
0.426 ±
0.276 ±
a: 1 vs 2
b: 1 vs 3
c: 2 vs 3
d: 2 vs 5
e: 3 vs 4
f: 3 vs 5
»: 4 vs 5
0.105a'b
0.113c'd
0.0730e-f
0.039*
0.007
0.362 ±
0.471 ±
0.844 ±
0.348 ±
0.241 ±
a: I vs 3
b: 2 vs 3
c: 2 vs 5
d: 3 vs 4
c: 3 vs 5
0.054
0.045b«c
0.940d-e
0.051
0.037
g-|
ο
JC
e.
G
c.
β
ζ
1.6 -
U ·
1.4-
1.2 -
1.1 ·
1 ·
0.9 -
0.8 ·
0.7 ·
0.6 -
0 J -
0.4-
0 J -
o0
t [min]
Fig. 3 Mean plasma norepinephrine concentrations during exercise and for 60 min after exercise in
normal and diabetic subjects. See figure 1 for key to abbreviations.
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Fig. 4 Mean plasma epinephrine concentrations during exercise and for 60 min after exercise in normal
and diabetic subjects. See figure 1 for key to abbreviations.
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moderate exercise (60% of maximal heart rate), blood
glucose concentrations were raised at 60 min into the
recovery period when compared with mid-exercise
levels (p < 0.05) and with resting levels, though the lat-
ter increase was not significant. In body mass index-
matched diabetic patients the rise in blood glucose in the
corresponding period was not significant. From studies
in healthy individuals it appears that the blood glucose
concentration does not remain stable during prolonged
exercise at - 50-60% VO2max or during intense exer-
cise, where hepatic glucose production is increased more
than is necessary to compensate for peripheral glucose
utilization (5). Following moderate exercise, Martin et
al. observed an increase in blood glucose concentration
in healthy controls while the opposite was true in non-
insulin-dependent diabetic patients exercising at the
same work intensity (1). Our findings in non-insulin-
dependent diabetics do not confirm these observations.
This discrepancy might be due to differences in the cate-
cholamine responses between the two studies. They ob-
served similar norepinephrine and epinephrine responses
in controls and in diabetics, while our findings showed
that though basal catecholamine values were similar in
both groups, non-insulin-dependent diabetic patients ex-
hibited an earlier (basal vs mid-exercise; p < 0.05 in
diabetics, not significant in controls) and prolonged
(basal vs recovery 20 and recovery 20 vs recovery 60
both p < 0.05 in diabetics) catecholamine response,
compared with controls. Catecholamines exert potent ef-
fects on glucose metabolism by stimulating lipolysis in
adipose tissue, thus inhibiting excessive glucose con-
sumption (1). They contribute to a great extent to the
maintenance of euglycaemia during and after exercise.
In the light of the results of previous studies we propose
that catecholamines are mainly responsible for the pre-
vention of exercise-induced hypoglycaemia in both con-
trols and diabetics in the present study, where insulin
and C-peptide concentrations did not change (1,16). An-
other possible explanation for the prevention of hypo-
glycaemia in this condition with no significant decre-
ments in insulin and C-peptide concentrations may be
that catecholamines stimulate hepatic glucose pro-
duction via glycogenolysis but have no significant effect
on glucose clearance (1, 16, 17).
Lactate, which accumulates as a result of enhanced gly-
cogenolysis stimulated by catecholamines, did not differ
between controls and diabetics at rest; it increased in a
similar manner in both groups, reaching maximal values
at the end of exercise and returned to resting values in
the 60 min of recovery. These findings are in accordance
with those of others (13). We observed a significant pos-
itive correlation between lactate and epinephrine values
in non-insulin-dependent diabetic patients (r = 0.903,
p < 0.02). Podolin et al. found a similar correlation in
their exercising subjects and reported a causal relation-
ship between lactate and epinephrine during exercise
(8).
The duration and intensity (14 min, 60% of maximal
heart rate) of exercise that was performed in this
study caused an earlier and prolonged increment in
catecholamines in the non-insulin-dependent diabetic
group, compared with the controls, and an increment
in blood glucose in both groups (though not significant
in diabetics) compared with the resting values. This
suggests that, especially in sedentary non-insulin-de-
pendent diabetic patients, the duration and intensity of
exercise should be lower than that performed in this
study, in order to benefit glucoregulation. Extension
of the study by monitoring the biochemical quantities
after several weeks of lower intensity exercise would
be worthwhile. Nevertheless, non-insulin-dependent di-
abetic patients with good metabolic control do not
seem to exhibit worse glucoregulatory responses to
exercise than controls with similar body mass indices
and levels of fitness.
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